Pain Management
Please note that you will be redirected to our sister website, EmergingSolutionsinPain.com (ESP) - Continuing Education Center, where these courses are maintained, unless otherwise noted. You will need to log in if you are already a member of the ESP website or take a minute to register for complimentary membership.
 | Clinical Dialogues in Pain for Nurses Kenneth L. Kirsh, PhD (Moderator) and Steven D. Passik, PhD | |
| Release Date: March 15, 2013 Expiration Date: March 15, 2014 | ||
| Dr. Kirsh and Dr. Passik discuss the importance of opioid agreements and their use for good communication as well as the importance of effective documentation when prescribing opioids in clinical practice. They will demonstrate these lessons through a clinical case in which a complex patient is prescribed opioids. Please Note: At the time of filming, Kenneth L. Kirsh, PhD, was affiliated with The Pain Treatment Center of the Bluegrass in Lexington, Kentucky and Steven D. Passik, PhD, was at Vanderbilt University Medical Center in Nashville, Tennessee. Their biographies and disclosures reflect these affiliations. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||
 | Effective Strategies in Managing Breakthrough Pain for Nurses Jeffrey A. Gudin, MD – Moderator, Lynn R. Webster, MD, FACPM, FASAM, and Michael J. Brennan, MD | |
| Release Date: September 28, 2012 Expiration Date: September 28, 2013 | ||
| This six-part activity has been designed to present nurses with the most up-to-date information in the assessment, treatment, and ongoing monitoring of patients who present with breakthrough pain. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||
 | Clinical Dialogues in Pain: Activity One ‒ Opioid Agreements: Tools for Good Communication in Clinical Practice Kenneth L. Kirsh, PhD (Moderator) and Steven D. Passik, PhD | |
| Release Date: February 13, 2013 Expiration Date: February 13, 2014 | ||
| Dr. Kirsh and Dr. Passik discuss the importance of opioid agreements and their use for good communication in the clinical practice. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||
 | Clinical Dialogues in Pain: Activity Two - Effective Documentation for Prescribing Opioids in Clinical Practice Kenneth L. Kirsh, PhD (Moderator) and Steven D. Passik, PhD | |
| Release Date: February 13, 2013 Expiration Date: February 13, 2014 | ||
| Dr. Kirsh and Dr. Passik discuss the importance of effective documentation when prescribing opioids in the clinical practice. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||
 | Clinical Dialogues in Pain: Activity Three - Challenges in Clinical Practice: A Complex Patient Who Is Prescribed Opioids Kenneth L. Kirsh, PhD (Moderator) and Steven D. Passik, PhD | |
| Release Date: February 13, 2013 Expiration Date: February 13, 2014 | ||
| Dr. Kirsh and Dr. Passik discuss a clinical case in which a complex patient is prescribed opioids and the challenges that arise. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||
 | Opioid Diversion: How, Where, and What Can We Do About It? Lynn R. Webster, MD, FACPM, FASAM ‒ Moderator; Commander John Burke; Kathryn L. Hahn, PharmD, DAAPM, CPE; and John J. Coleman, PhD | |
| Release Date: December 13, 2012 Expiration Date: December 13, 2013 | ||
| Dr. Lynn Webster leads a discussion with a panel of experts on opioid diversion in pain management, how it is happening, where it is happening, and what we can do about it. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||
| Effective Strategies in Managing Breakthrough Pain: Introduction Jeffrey A. Gudin, MD | |
| Begin | ||
 | Effective Strategies in Managing Breakthrough Pain: Activity One - Effective Assessment of Breakthrough Pain Jeffrey A. Gudin, MD | |
| Release Date: August 30, 2012 Expiration Date: August 30, 2013 | ||
| A two-part activity focusing on appropriate and individualized assessment of breakthrough pain. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||
 | Effective Strategies in Managing Breakthrough Pain: Activity Two - Individualized Approaches to the Treatment of Breakthrough Pain Jeffrey A. Gudin, MD - Moderator, and Lynn R. Webster, MD, FACP, FASAM | |
| Release Date: August 30, 2012 Expiration Date: August 30, 2013 | ||
| A two-part activity focusing on proper patient selection and appropriate pharmacological treatments for breakthrough pain. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||
 | Effective Strategies in Managing Breakthrough Pain: Activity Three - Risk Management Strategies in Breakthrough Pain Jeffrey A. Gudin, MD – Moderator, and Michael J. Brennan, MD | |
| Release Date: August 30, 2012 Expiration Date: August 30, 2013 | ||
| A two-part activity focusing on risk mitigation in a real-world setting. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||
 | Effective Strategies in Managing Breakthrough Pain: Activity Four ‒ Effective Strategies in Managing Breakthrough Pain Jeffrey A. Gudin, MD - Moderator; Michael J. Brennan, MD; Lynn R. Webster, MD, FACPM, FASAM | |
| Release Date: December 04, 2012 Expiration Date: December 04, 2013 | ||
| Dr. Jeffrey Gudin leads a panel of experts in a clinical case discussion focusing on the assessment, diagnosis, and treatment of breakthrough pain. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from Teva Pharmaceuticals. | ||
| Begin | ||